BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2474883)

  • 21. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD; Crook JM; Lukka H
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Half-body irradiation in the treatment of metastatic prostatic carcinoma.
    Rowland CG; Bullimore JA; Smith PJ; Roberts JB
    Br J Urol; 1981 Dec; 53(6):628-9. PubMed ID: 6172173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemi body irradiation: An economical way of palliation of pain in bone metastasis in advanced cancer.
    Pal S; Dutta S; Adhikary SS; Bhattacharya B; Ghosh B; Patra NB
    South Asian J Cancer; 2014 Jan; 3(1):28-32. PubMed ID: 24665443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate.
    Kuban DA; Delbridge T; el-Mahdi AM; Schellhammer PF
    J Urol; 1989 Mar; 141(3):572-4. PubMed ID: 2465419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.
    Palmedo H; Manka-Waluch A; Albers P; Schmidt-Wolf IG; Reinhardt M; Ezziddin S; Joe A; Roedel R; Fimmers R; Knapp FF; Guhlke S; Biersack HJ
    J Clin Oncol; 2003 Aug; 21(15):2869-75. PubMed ID: 12885803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Palliative radiotherapy for local progression of hormone refractory stage D2 prostate cancer].
    Kawakami S; Kawai T; Yonese J; Yamauchi T; Ishibashi K; Ueda T
    Nihon Hinyokika Gakkai Zasshi; 1993 Sep; 84(9):1681-4. PubMed ID: 7692124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy for the palliation of painful bone metastases.
    McQuay HJ; Collins SL; Carroll D; Moore RA
    Cochrane Database Syst Rev; 2000; (2):CD001793. PubMed ID: 10796822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
    Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
    Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Half-body irradiation. Palliative efficacy and predictive factors of response in 78 procedures].
    Algara M; Valls A; Ruiz V; Jaume M; Lacruz M; Foro P
    Med Clin (Barc); 1994 Jun; 103(3):85-8. PubMed ID: 8065222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early combined hormonal and chemotherapy for metastatic prostatic carcinoma.
    Servadio C; Mukamel E; Lurie H; Nissenkorn I
    Urology; 1983 May; 21(5):493-5. PubMed ID: 6857889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-fractionated wide-field radiation therapy for palliation of multiple symptomatic bone metastases from solid tumors.
    Hayashi S; Hoshi H; Iida T; Kajiura Y
    Radiat Med; 1999; 17(6):411-6. PubMed ID: 10646976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?
    Leo ME; Bilhartz DL; Bergstralh EJ; Oesterling JE
    J Urol; 1991 Apr; 145(4):802-6. PubMed ID: 1706440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of 3D-conformal half body irradiation in patients with multiple bone metastases.
    Macchia G; Ferro M; Cilla S; Buwenge M; Ianiro A; Boccardi M; Picardi V; Ferro M; Arena E; Zamagni A; Cammelli S; Valentini V; Morganti AG; Deodato F
    Clin Exp Metastasis; 2018 Dec; 35(8):747-752. PubMed ID: 30251079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the usefulness of hemibody irradiation in painful bone metastasis.
    Biswal BM
    J Indian Med Assoc; 2004 Mar; 102(3):133-4, 136-7. PubMed ID: 15473272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.
    Robinson RG; Blake GM; Preston DF; McEwan AJ; Spicer JA; Martin NL; Wegst AV; Ackery DM
    Radiographics; 1989 Mar; 9(2):271-81. PubMed ID: 2467331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External beam radiotherapy for palliation of pain from metastatic carcinoma of the prostate.
    Benson RC; Hasan SM; Jones AG; Schlise S
    J Urol; 1982 Jan; 127(1):69-71. PubMed ID: 6173495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP ].
    Dolezal J; Vizd'a J; Cermáková E
    Vnitr Lek; 2003 Mar; 49(3):189-93. PubMed ID: 12728593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic radionuclide therapy in pain palliation.
    Liepe K; Runge R; Kotzerke J
    Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Half body irradiation for palliation of widespread metastatic bone disease.
    Chua ET; Chua EJ; Sethi VK
    Ann Acad Med Singap; 1994 Mar; 23(2):204-8. PubMed ID: 7521611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined treatment for pain from bone metastases in patients with prostate cancer].
    Ren X; Ying J; Yao D; Ye C; Jiang Y
    Zhonghua Nan Ke Xue; 2004 Mar; 10(3):188-90. PubMed ID: 15080063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.